--- schema_version: "secwatch.filing_event.v1" accession: "0001437749-24-010069" form_type: "8-K" ticker: "OPK" cik: "0000944809" company_name: "OPKO HEALTH, INC." filed_at: "2024-03-29T23:59:59+00:00" generated_at: "2026-06-04T05:39:09.743585+00:00" event_type: "other_material" sentiment: "neutral" materiality_score: 0.3 calibrated_materiality_score: 0.15 confidence: "high" source: SEC EDGAR --- # OPKO Health stockholders approve share increase to 1.25B, elect all 11 directors ## Summary - Authorized share increase from 1B to 1.25B approved with 492.4M for, 37.9M against. - All 11 director nominees elected; votes ranged from 409.3M to 438.3M for each. - Non-binding advisory vote on named executive officer compensation passed with 431.1M for. - Ratification of Ernst & Young as independent auditor for FY2024 approved with 519.6M for. ## SEC filing metadata - accession: 0001437749-24-010069 - form_type: 8-K - ticker: OPK - cik: 0000944809 - company_name: OPKO HEALTH, INC. - filed_at: 2024-03-29T23:59:59+00:00 - event_type: other_material - sentiment: neutral - materiality_score: 0.3 - calibrated_materiality_score: 0.15 - confidence: high - sec_items: 5.07 - EDGAR index: https://www.sec.gov/Archives/edgar/data/944809/000143774924010069/0001437749-24-010069-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/944809/000143774924010069/opk20240220c_8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001437749-24-010069 - JSON: https://secwatch.observer/filing/0001437749-24-010069.json - Plain text: https://secwatch.observer/filing/0001437749-24-010069.txt ## Key facts - Shareholder Votes OPKO HEALTH, INC. shareholders approved Amendment to the Company’s amended and restated certificate of incorporation to increase the authorized number of shares of the Company’s Common Stock that the Company may issue from 1,000,000,000 shares to 1,250,000,000 shares at the 2024-03-28 meeting. - Proposal: charter amendment - Outcome: passed - Meeting: 2024-03-28 source text: 2. The stockholders voted to approve an amendment to the Company’s amended and restated certificate of incorporation to increase the authorized number of shares of the Company’s Common Stock that the Company may issue from 1,000,000,000 shares to 1,250,000,000 shares as disclosed in the 2024 Proxy Statement for the Annual Meeting. The votes on the OPKO authorized share increase proposal were as follows: For Against Abstain 492,393,778 37,918,739 985,314 evidence_url: https://www.sec.gov/Archives/edgar/data/944809/000143774924010069/0001437749-24-010069-index.htm - Shareholder Votes OPKO HEALTH, INC. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-03-28 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2024-03-28 source text: 4. The stockholders voted to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. The votes on this proposal were as follows: For Against Abstain Broker Non-Votes 519,634,618 10,186,987 1,476,226 0 evidence_url: https://www.sec.gov/Archives/edgar/data/944809/000143774924010069/0001437749-24-010069-index.htm - Shareholder Votes OPKO HEALTH, INC. shareholders approved Election of Directors at the 2024-03-28 meeting. - Proposal: director election - Outcome: passed - Meeting: 2024-03-28 source text: 1. All eleven nominees were elected to the Board of Directors with each director receiving votes as follows: Election of Directors For Against Abstain Broker Non-Votes Phillip Frost, M.D. 417,952,041 22,474,563 6,171,466 84,699,761 Jane H. Hsiao, Ph.D. 413,880,317 26,420,093 6,297,660 84,699,761 Elias A. Zerhouni, M.D. 414,360,287 26,147,182 6,090,601 84,699,761 Steven D. Rubin 409,265,433 31,259,959 6,072,678 84,699,761 Gary J. Nabel, M.D., Ph.D. 414,266,144 26,217,873 6,114,053 84,699,761 Richard M. Krasno, Ph.D. 433,053,909 12,897,229 646,932 84,699,761 Prem A. Lachman, M.D. 435,390,598 10,489,096 718,376 84,699,761 Roger J. Medel, M.D. 435,237,621 10,618,192 742,257 84,699,761 John A. Paganelli 415,788,107 29,404,640 1,405,323 84,699,761 Richard C. Pfenniger, Jr. 419,052,214 26,216,424 1,329,432 84,699,761 Alice Lin-Tsing Yu, M.D., Ph.D. 438,269,264 7,742,819 585,987 84,699,761 evidence_url: https://www.sec.gov/Archives/edgar/data/944809/000143774924010069/0001437749-24-010069-index.htm - Shareholder Votes OPKO HEALTH, INC. shareholders approved Non-binding advisory vote to approve the compensation of the named executive officers at the 2024-03-28 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2024-03-28 source text: 3. The stockholders voted to approve, on a non-binding advisory basis, the compensation of the named executive officers of the Company as disclosed in the Company’s 2024 Proxy Statement for the Annual Meeting. The votes on this proposal were as follows: For Against Abstain Broker Non-Votes 431,121,613.12 13,954,192 1,522,264.675 84,699,761 evidence_url: https://www.sec.gov/Archives/edgar/data/944809/000143774924010069/0001437749-24-010069-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.